ADME Toxicology Testing Market Research Report – Global Forecast till 2027

ADME Toxicology Testing Market Research Report, by Method (Cellular Assay, Ex-vivo), Technology (Cell Culture, Biochemical Assay, Molecular Imaging), Application (Systemic, Renal), End-User (Hospital & Clinic, Diagnostic Centre) – Global Forecast Till 2027

ID: MRFR/LS/5480-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018–2022 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


ADME Toxicology Screening System are integrated workstation that describing of the absorption, distribution, metabolism, and excretion properties of drug molecules. The system is enabled with highly integrated software that is used for sample testing. Moreover, it provides accurate toxicity test for the drug development and biopharmaceutical production. The key factor responsible for influencing this market is the rising application of ADME toxicology testing by pharmaceuticals and biotechnology companies, and growing concerns over application of animals in clinical trials have aided the growth of the toxicology testing market. However, factors such as, lack of in-vitro models to detect autoimmunity and immune-stimulation are expected to restrict the market growth during the forecast period.


The Global ADME Toxicology Testing Market size is projected to register a CAGR of 11.4% over the forecast period.


Segmentation:


The global ADME Toxicology Testing Market is segmented on the basis of method, technology, application, and end-user. The ADME Toxicology Testing Market , by method is categorised into cellular assay, biochemical assay, in silica, and ex-vivo. The technology segment is categorised into cell culture, high throughput, molecular imaging, and OMICS technology. On the basis of application, the ADME Toxicology Testing Market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centres, pathological labs, and others.


On the basis of region, the global ADME Toxicology Testing Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players: Some of the key players in the global ADME toxicology testing market are Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc.,  Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Caliper Life Sciences, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., CeeTox, Inc., and others.


Regional Market Summary


Global ADME toxicology testing Market Share (%), by Region, 2017


Sources: National Cancer Institute, Cancer research UK, the American Cancer Society, Inc, US Department of Health and Human Services National Institutes of Health


It is projected that the Americas dominated the global ADME toxicology testing market owing to the growth in the North America region which is largely attributed to the factors such as increase in research funding, growing awareness on the benefits of ADME toxicology testing for commercial industries, and high adoption of toxicology testing in research. These factors have cumulatively influenced the growth of the market in this regionEurope stood second largest in the ADME toxicology testing market owing to high acceptance of toxicology testing in research. Additionally, development in research expenditure was also responsible for the development of ADME toxicology testing market. Moreover, in January 2014, Cyprotex PLC, a UK based company signed an acquisition agreement with CeeTox, Inc. for its business. The company intended to expand its portfolio for in-vitro toxicity assays and screening services to the Cosmetics and Personal Care Industry.


Asia-Pacific was projected to be the fastest growing region for the global ADME toxicology testing market in 2017. The factors attributed to the due to increased efforts for development of new diagnostic devices and adoption of newer technologies to improve the standard of diagnostics assays being supplied. China and Japan are key countries contributing to market growth.The Middle East and Africa holds the least share in the global ADME toxicology testing market due to the presence of poor health expenditure and economically diverse countries. However, the market is expected to witness growth due to increasing toxicology care programs in the Middle East.


Intended Audience:



  • Pharmaceutical companies

  • Biotechnological institutes

  • Diagnostics Laboratories

  • Pathological Institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers


Market Segmentation and Key Market Players:


Global ADME toxicology testing Market, by Method:



  •        Cellular Assay

  •        Biochemical Assay

  •        In Silica

  •        Ex-vivo


Global ADME toxicology testing Market, by Technology:



  •        Cell Culture

  •        High Throughput

  •        Molecular Imaging

  •        OMICS Technology


Global ADME toxicology testing Market, by Application:



  •        Systemic Toxicity

  •        Renal Toxicity

  •        Hepatotoxicity

  •        Neurotoxicity

  •        Others


Global ADME toxicology testing Market, by End-Users:



  •       Hospitals and clinics

  •       Diagnostic centers

  •       Pathological Labs

  •       Others


Global ADME toxicology testing Market, by Region:



  •        Americas

  •        Europe

  •        Asia-Pacific

  •       Middle East & Africa


Global ADME toxicology testing Market, by Key Players:



  •        Promega Corporation

  •        Agilent Technologies, Inc.

  •        Thermo Fisher Scientific, Inc.

  •        Bio-Rad Laboratories, Inc.

  •        Beckman Coulter, Inc.

  •        Cellartis AB

  •        Cyprotex PLC.

  •        Life Technologies Corporation

  •        Optivia Biotechnology, Inc.

  •        Accelrys, Inc.

  •        Molecular Discovery Ltd.

  •        Cyprotex PLC

  •        MultiCASE, Inc.


 


 


 


 



TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global ADME Toxicology Testing Market, by Method

6.1 Introduction

6.2 Cellular Assay

6.3 Biochemical Assay

6.4 In Silica

6.5 Ex-vivo

Chapter 7. Global ADME Toxicology Testing Market, by Technology

7.1 Introduction

7.2 Cell Culture

7.3 High Throughput

7.4 Molecular Imaging

7.5 OMICS Technology Cameras

Chapter 8. Global ADME Toxicology Testing Market, by Applications

8.1 Introduction

8.2 Systemic Toxicity

8.3 Renal Toxicity

8.4 Hepatotoxicity

8.5 Neurotoxicity

8.6 Others

Chapter 9. Global ADME Toxicology Testing Market, by End-Users

9.1 Introduction

9.2 Hospitals and clinics

9.3 Diagnostic Centers

9.4 Pathological Labs

9.5 Others

Chapter 10. Global ADME Toxicology Testing Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 UK

10.3.1.3 Italy

10.3.1.4 France

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 The Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12 Company Profiles

12.1 Accelrys, Inc.

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Agilent Technologies, Inc.

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Caliper Life Sciences, Inc.

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Company Overview

12.4.2 Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Beckman Coulter, Inc.

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Cellartis AB

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Cyprotex PLC.

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Life Technologies Corporation

12.8.1 Overview

12.8.2 Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Optivia Biotechnology, Inc.

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Thermo Fisher Scientific, Inc.

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Molecular Discovery Ltd.

12.11.1 Overview

12.11.2 Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Promega Corporation

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Others

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global ADME toxicology testing Market Industry Synopsis, 2020-2027

Table 2 Global ADME toxicology testing Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global ADME toxicology testing Market, by Region, 2020-2027, (USD Million)

Table 4 Global ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 5 Global ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 6 Global ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 7 Global ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 8 North America: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 9 North America: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 10 North America: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 11 North America: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 12 US: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 13 US: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 14 US: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 15 US: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 16 Canada: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 17 Canada: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 18 Canada: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 19 Canada: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 20 South America: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 21 South America: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 22 South America: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 23 South America: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 24 Europe: ADME toxicology testing Market, Method, 2020-2027, (USD Million)

Table 25 Europe: ADME toxicology testing Market, Technology, 2020-2027, (USD Million)

Table 26 Europe: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 27 Europe: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 28 Western Europe: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 29 Western Europe: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 30 Western Europe: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 31 Western Europe: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 32 Eastern Europe: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 33 Eastern Europe: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 34 Eastern Europe: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 35 Eastern Europe: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 36 Asia-Pacific: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 37 Asia-Pacific: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 38 Asia-Pacific: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 39 Asia-Pacific: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

Table 40 Middle East & Africa: ADME toxicology testing Market, by Method, 2020-2027, (USD Million)

Table 41 Middle East & Africa: ADME toxicology testing Market, by Technology, 2020-2027, (USD Million)

Table 42 Middle East & Africa: ADME toxicology testing Market, by Application, 2020-2027, (USD Million)

Table 43 Middle East & Africa: ADME toxicology testing Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for the Global ADME toxicology testing Market

Figure 3 Market Dynamics for the Global ADME toxicology testing Market

Figure 4 Global ADME toxicology testing Market Share, by Method 2020

Figure 5 Global ADME toxicology testing Market Share, by Technology 2020

Figure 6 Global ADME toxicology testing Market Share, by Application, 2020

Figure 7 Global ADME toxicology testing Market Share, by End-User, 2020

Figure 8 Global ADME toxicology testing Market Share, by Region, 2020

Figure 9 North America ADME toxicology testing Market Share, by Country, 2020

Figure 10 Europe Prescribed Health Apps Share, by Country, 2020

Figure 11 Asia-Pacific ADME toxicology testing Market Share, by Country, 2020

Figure 12 Middle East & Africa ADME toxicology testing Market Share, by Country, 2020

Figure 13 Global ADME toxicology testing Market: Company Share Analysis, 2020 (%)

Figure 14 Accelrys, Inc: Key Financials

Figure 15 Accelrys, Inc: Segmental Revenue

Figure 16 Accelrys, Inc: Geographical Revenue

Figure 17 Agilent Technologies, Inc.: Key Financials

Figure 18 Agilent Technologies, Inc.: Segmental Revenue

Figure 19 Agilent Technologies, Inc.: Geographical Revenue

Figure 20 Caliper Life Sciences, Inc. : Key Financials

Figure 21 Caliper Life Sciences, Inc. : Segmental Revenue

Figure 22 Caliper Life Sciences, Inc. : Geographical Revenue

Figure 23 Bio-Rad Laboratories, Inc: Key Financials

Figure 24 Bio-Rad Laboratories, Inc: Segmental Revenue

Figure 25 Bio-Rad Laboratories, Inc: Geographical Revenue

Figure 26 Beckman Coulter, Inc.: Key Financials

Figure 27 Beckman Coulter, Inc.: Segmental Revenue

Figure 28 Beckman Coulter, Inc.: Geographical Revenue

Figure 29 Cellartis AB: Key Financials

Figure 30 Cellartis AB: Segmental Revenue

Figure 31 Cellartis AB: Geographical Revenue

Figure 32 Cyprotex PLC: Key Financials

Figure 33 Cyprotex PLC: Segmental Revenue

Figure 34 Cyprotex PLC: Geographical Revenue